DK175442B1 - Apparatus for dispensing substances and method of manufacture and use thereof - Google Patents
Apparatus for dispensing substances and method of manufacture and use thereof Download PDFInfo
- Publication number
- DK175442B1 DK175442B1 DK198902102A DK210289A DK175442B1 DK 175442 B1 DK175442 B1 DK 175442B1 DK 198902102 A DK198902102 A DK 198902102A DK 210289 A DK210289 A DK 210289A DK 175442 B1 DK175442 B1 DK 175442B1
- Authority
- DK
- Denmark
- Prior art keywords
- melt adhesive
- weight
- substance
- optionally
- substances
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000004831 Hot glue Substances 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000012545 processing Methods 0.000 claims abstract description 8
- 238000009827 uniform distribution Methods 0.000 claims abstract description 3
- 239000000853 adhesive Substances 0.000 claims description 49
- 230000001070 adhesive effect Effects 0.000 claims description 49
- 239000000155 melt Substances 0.000 claims description 26
- 239000010410 layer Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000000945 filler Substances 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000004014 plasticizer Substances 0.000 claims description 6
- 239000011241 protective layer Substances 0.000 claims description 6
- 229920002367 Polyisobutene Polymers 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 229920001610 polycaprolactone Polymers 0.000 claims description 3
- 229920000647 polyepoxide Polymers 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920001289 polyvinyl ether Polymers 0.000 claims description 3
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 238000007639 printing Methods 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000013008 thixotropic agent Substances 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims 1
- 238000005266 casting Methods 0.000 claims 1
- 238000009828 non-uniform distribution Methods 0.000 abstract 1
- 239000011253 protective coating Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 description 40
- -1 indicator systems Substances 0.000 description 19
- 229920005989 resin Polymers 0.000 description 14
- 239000011347 resin Substances 0.000 description 14
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 11
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 11
- 150000002148 esters Chemical class 0.000 description 11
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 11
- 239000012790 adhesive layer Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000013032 Hydrocarbon resin Substances 0.000 description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical class OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 8
- KBAYQFWFCOOCIC-GNVSMLMZSA-N [(1s,4ar,4bs,7s,8ar,10ar)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-1-yl]methanol Chemical compound OC[C@@]1(C)CCC[C@]2(C)[C@H]3CC[C@H](C(C)C)C[C@H]3CC[C@H]21 KBAYQFWFCOOCIC-GNVSMLMZSA-N 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 229920006270 hydrocarbon resin Polymers 0.000 description 8
- 229920002689 polyvinyl acetate Polymers 0.000 description 6
- 239000004744 fabric Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229940100640 transdermal system Drugs 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000002519 antifouling agent Substances 0.000 description 2
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 229920006244 ethylene-ethyl acrylate Polymers 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229960002428 fentanyl Drugs 0.000 description 2
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 2
- 229960002646 scopolamine Drugs 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical class [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- SLRCCWJSBJZJBV-LXTVHRRPSA-N (-)-Spartein Natural products C1N2CCCC[C@@H]2[C@H]2CN3CCCC[C@@H]3[C@H]1C2 SLRCCWJSBJZJBV-LXTVHRRPSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- ZWLMLVIUWRUDBD-BTJKTKAUSA-N (z)-but-2-enedioate;3-(2-methoxy-10h-phenothiazin-10-ium-10-yl)propyl-dimethylazanium Chemical compound OC(=O)\C=C/C(O)=O.C1=CC=C2N(CCCN(C)C)C3=CC(OC)=CC=C3SC2=C1 ZWLMLVIUWRUDBD-BTJKTKAUSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- JWDYCNIAQWPBHD-UHFFFAOYSA-N 1-(2-methylphenyl)glycerol Chemical compound CC1=CC=CC=C1OCC(O)CO JWDYCNIAQWPBHD-UHFFFAOYSA-N 0.000 description 1
- KVHHQGIIZCJATJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethyl-2-butanol Chemical compound CN(C)CC(C)C(C)(O)CC1=CC=C(Cl)C=C1 KVHHQGIIZCJATJ-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 description 1
- IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 description 1
- ROGIWVXWXZRRMZ-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1 ROGIWVXWXZRRMZ-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- IKQUUYYDRTYXAP-UHFFFAOYSA-N 3-methylpenta-1,4-diene Chemical compound C=CC(C)C=C IKQUUYYDRTYXAP-UHFFFAOYSA-N 0.000 description 1
- PFEOZHBOMNWTJB-UHFFFAOYSA-N 3-methylpentane Chemical compound CCC(C)CC PFEOZHBOMNWTJB-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 229920004939 Cariflex™ Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AJXPJJZHWIXJCJ-UHFFFAOYSA-N Methsuximide Chemical compound O=C1N(C)C(=O)CC1(C)C1=CC=CC=C1 AJXPJJZHWIXJCJ-UHFFFAOYSA-N 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920005987 OPPANOL® Polymers 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- WLWFNJKHKGIJNW-UHFFFAOYSA-N Phensuximide Chemical compound O=C1N(C)C(=O)CC1C1=CC=CC=C1 WLWFNJKHKGIJNW-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- IFFPICMESYHZPQ-UHFFFAOYSA-N Prenylamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)CCNC(C)CC1=CC=CC=C1 IFFPICMESYHZPQ-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000001171 adenosinetriphosphoric effect Effects 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 150000001278 adipic acid derivatives Chemical class 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 229920006271 aliphatic hydrocarbon resin Polymers 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- NFHVTCJKAHYEQN-UHFFFAOYSA-N amfetaminil Chemical compound C=1C=CC=CC=1C(C#N)NC(C)CC1=CC=CC=C1 NFHVTCJKAHYEQN-UHFFFAOYSA-N 0.000 description 1
- 229950000762 amfetaminil Drugs 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 229920006272 aromatic hydrocarbon resin Polymers 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 229960001498 benactyzine Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- NTXGQCSETZTARF-UHFFFAOYSA-N buta-1,3-diene;prop-2-enenitrile Chemical compound C=CC=C.C=CC#N NTXGQCSETZTARF-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
- 229960003609 cathine Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
- 229960002881 clemastine Drugs 0.000 description 1
- 229960002735 clobutinol Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012936 correction and preventive action Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- OWQIUQKMMPDHQQ-UHFFFAOYSA-N dimethocaine Chemical compound CCN(CC)CC(C)(C)COC(=O)C1=CC=C(N)C=C1 OWQIUQKMMPDHQQ-UHFFFAOYSA-N 0.000 description 1
- 229950010160 dimethocaine Drugs 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- MSYUMPGNGDNTIQ-UHFFFAOYSA-N dixyrazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC(C)CN1CCN(CCOCCO)CC1 MSYUMPGNGDNTIQ-UHFFFAOYSA-N 0.000 description 1
- 229960005146 dixyrazine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- SLWGJZPKHAXZQL-UHFFFAOYSA-N emylcamate Chemical compound CCC(C)(CC)OC(N)=O SLWGJZPKHAXZQL-UHFFFAOYSA-N 0.000 description 1
- 229960000650 emylcamate Drugs 0.000 description 1
- AXJXURWWUFZZKN-UHFFFAOYSA-N enallylpropymal Chemical compound C=CCC1(C(C)C)C(=O)NC(=O)N(C)C1=O AXJXURWWUFZZKN-UHFFFAOYSA-N 0.000 description 1
- 229950009181 enallylpropymal Drugs 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- 229960000305 enflurane Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- UVTJKLLUVOTSOB-UHFFFAOYSA-N etaqualone Chemical compound CCC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C UVTJKLLUVOTSOB-UHFFFAOYSA-N 0.000 description 1
- 229950010472 etaqualone Drugs 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- 229960002767 ethosuximide Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000005042 ethylene-ethyl acrylate Substances 0.000 description 1
- 229960001493 etofenamate Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- WFLSCFISQHLEED-UHFFFAOYSA-N isoaminile Chemical compound CN(C)C(C)CC(C(C)C)(C#N)C1=CC=CC=C1 WFLSCFISQHLEED-UHFFFAOYSA-N 0.000 description 1
- 229960004216 isoaminile Drugs 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960003861 mephenesin Drugs 0.000 description 1
- 229960003729 mesuximide Drugs 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229950008620 methopromazine Drugs 0.000 description 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 1
- 229960002455 methoxyflurane Drugs 0.000 description 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 1
- QXLPXWSKPNOQLE-UHFFFAOYSA-N methylpentynol Chemical compound CCC(C)(O)C#C QXLPXWSKPNOQLE-UHFFFAOYSA-N 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 229960000316 methyprylon Drugs 0.000 description 1
- MJFJKKXQDNNUJF-UHFFFAOYSA-N metixene Chemical compound C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 MJFJKKXQDNNUJF-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960005249 misoprostol Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229960003226 nikethamide Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
- 229960002195 perazine Drugs 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 229960003534 phenindamine Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- 229960004227 phensuximide Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229950006768 phenylethanolamine Drugs 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 150000003021 phthalic acid derivatives Chemical class 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- FWWDFDMCZLOXQI-UHFFFAOYSA-N pivhydrazine Chemical compound CC(C)(C)C(=O)NNCC1=CC=CC=C1 FWWDFDMCZLOXQI-UHFFFAOYSA-N 0.000 description 1
- 229950008099 pivhydrazine Drugs 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960001989 prenylamine Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- CDOZDBSBBXSXLB-UHFFFAOYSA-N profenamine Chemical compound C1=CC=C2N(CC(C)N(CC)CC)C3=CC=CC=C3SC2=C1 CDOZDBSBBXSXLB-UHFFFAOYSA-N 0.000 description 1
- 229960002262 profenamine Drugs 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229960002784 thioridazine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960003741 tranylcypromine Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical class OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940048102 triphosphoric acid Drugs 0.000 description 1
- PRBORDFJHHAISJ-UHFFFAOYSA-N tybamate Chemical compound CCCCNC(=O)OCC(C)(CCC)COC(N)=O PRBORDFJHHAISJ-UHFFFAOYSA-N 0.000 description 1
- 229960002560 tybamate Drugs 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Coating Apparatus (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Containers And Plastic Fillers For Packaging (AREA)
- Extrusion Moulding Of Plastics Or The Like (AREA)
- Refuse Collection And Transfer (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Lubricants (AREA)
Abstract
Description
DK 175442 B1 iDK 175442 B1 i
Opfindelsen angår en indretning til afgivelse af stoffer fra smelteklæbemidler, med uensartet eller ensartet fordeling af stof i smelteklæbemidlerne, fremgangsmåde til fremstilling deraf og dens anvendelse.The invention relates to a device for dispensing substances from melt adhesives, with a uniform or uniform distribution of substance in the melt adhesives, a method of making them and its use.
5 Typiske repræsentanter for sådanne indretninger er plastre med indhold af aktivt stof, indikatorsystemer, duftstofsafgivende indretninger og lignende, hvorfor disse især bliver anvendt inden for det medicinske område til reguleret eller ureguleret afgivelse af stoffer. Herved har de regulerende indretninger opnået en særlig betydning i form af transdermalt regulerede systemer. Til sådanne systemer er det 10 allerede kendt i smeltet tilstand at påføre et lag med aktivt stof. Fra EP-A 0177893 kendes en i smeltet tilstand påførbar ikke-klæbende celluloseethergel, i hvilken det aktive stof kan være fordelt. Denne gel forarbejdes varm og er ikke-klæbende. Fra DE-OS 32 22 800 kendes et transdermalt system, i hvilket aktivt stof, der er indeholdt i mikrokapsler, foreligger i et termisk formbart, klæbende 15 matrixmateriale, som påføres i smeltet tilstand.Typical representatives of such devices are patches containing active substance, indicator systems, fragrance-releasing devices and the like, which are why they are especially used in the medical field for controlled or unregulated drug delivery. In this way, the regulating devices have gained a special importance in the form of transdermally regulated systems. For such systems, it is already known in the molten state to apply a layer of active substance. EP-A-0177893 discloses a non-sticky cellulose ether gel which can be applied in the molten state in which the active substance can be distributed. This gel is processed hot and is non-sticky. DE-OS 32 22 800 discloses a transdermal system in which the active substance contained in microcapsules is present in a thermally malleable, adhesive matrix material which is applied in a molten state.
I US-P-4515909 er beskrevet genstande, hvor polymerer ved forhøjet temperatur i fast tilstand imprægneres med duftstof. Ifølge dette patentskrift smeltes polymeren ikke, men en noget blødgjort polymer imprægneres med duftstoffet ved forhøjede 20 temperaturer.US-P-4515909 discloses articles in which polymers at solid temperature are impregnated with fragrance. According to this patent, the polymer is not melted, but a somewhat softened polymer is impregnated with the fragrance at elevated temperatures.
Denne fremgangsmåde egner sig ikke til nøjagtig påførsel af definerede mængder i en polymer. 1 2 3 4 5 6This method is not suitable for accurate application of defined amounts in a polymer. 1 2 3 4 5 6
For temperaturfølsomme aktive stoffer med lavt smeltepunkt eller let nedbrydelige 2 stoffer er det også blevet forsøgt ved stuetemperatur at fremstille ikke-klæbende 3 matricer med virksomt stof. Eksempelvis angives det i US-PS 4.379.454 (Campbell 4 et al.) som aktivt stoflag at anvende en opløsning af aktivt stof, som ved hjælp af 5 et geleringsmiddel ved stuetemperatur er blevet bragt til en ønsket viskositet. Fra 6 US-PS 4.559.222 (Enscore et al.) er det kendt at anvende en ved stuetemperatur fremstillet blanding af mineralolie/polyisobutylen og kolloidt siliciumdioxid som viskøst aktivt stoflag for olieopløselige aktive stoffer, idet disse lag også kan gøres klæbende. DE-OS 32 22 800 (ALZA) beskriver et aktivt stoflag bestående af en opløsning af aktivt stof, som er fortykket med et rheologisk middel såsom cellulose,For temperature sensitive active substances with low melting point or easily degradable 2 substances, it has also been attempted at room temperature to produce non-sticky 3 matrices with active substance. For example, in US Patent 4,379,454 (Campbell 4 et al.), It is stated as the active substance layer to use a solution of active substance which has been brought to a desired viscosity by means of a gelling agent at room temperature. From US Pat. No. 4,559,222 (Enscore et al.), It is known to use a room-temperature mixture of mineral oil / polyisobutylene and colloidal silica as viscous active substance layer for oil-soluble active substances, as these layers can also be made adhesive. DE-OS 32 22 800 (ALZA) describes an active substance layer consisting of a solution of active substance thickened with a rheological agent such as cellulose,
DK 175442 B1 IDK 175442 B1 I
et polysaccharid eller en siliciumforbindelse, som ikke er klæbende, og som egner Ia non-adhesive polysaccharide or a silicon compound suitable for use in
sig til hurtig afgivelse af aktivt stof. Ifor rapid release of active substance. IN
Fra US-PS 3.923.939 kendes det at forme aktive stoffer såsom tetracydin til et IFrom US-PS 3,923,939 it is known to form active substances such as tetracydine into an I
5 ethylen-vinylacetat-copolymerlag ved smeltepresning. EP-A 86 468 bliver et oralt I5 ethylene-vinyl acetate copolymer layers by melt pressing. EP-A 86 468 becomes an oral I
antidiabetisk sulfonylurinstofderivat i en ikke-klæbende varmsmeltemasse med et Iantidiabetic sulfonylurea derivative in a non-adhesive hot melt with an I
smeltepunkt fra 306C til 90C påfyldt kapsler i forudbestemte doser og i smeltet Imelting point from 306C to 90C filled capsules in predetermined doses and in melted I
tilstand. I US-PS 3.957.966 er det beskrevet, at aktive stoffer kan forarbejdes i Icondition. U.S. Pat. No. 3,957,966 discloses that active substances can be processed in I
ikke-klæbende varmsmeltemasser. Inon-adhesive hot melt. IN
Fra DE-A 30 07 363 er det kendt at anvende en klæbende blanding af en IFrom DE-A 30 07 363 it is known to use an adhesive mixture of an I
termoplastisk elastomer, her fortrinsvis en blokpolymer med den almene formel A- Ithermoplastic elastomer, preferably a block polymer of general formula A-I
B-A, en klæbriggørende harpiks med olie eller højere fedtsyrer og aktivt stof til IB-A, an adhesive resin with oil or higher fatty acids and active substance for I
fremstilling af et simpelt transdermalt system. Den der beskrevne klæbeblanding Ipreparation of a simple transdermal system. The adhesive composition described herein
15 egner sig kun til relativt temperaturresistente aktive stoffer, der kan tåle tempe- I15 is suitable only for relatively temperature resistant active substances which can withstand temperature
raturer på 120°C eller mere. J Itemperatures of 120 ° C or more. J I
I US-PS 3.699.963 er det beskrevet, at oxytocin til fremstilling af et transdermalt IU.S. Pat. No. 3,699,963 discloses oxytocin for the preparation of a transdermal I
terapeutisk system kan blandes med klæbemiddel og formes ved en temperatur påtherapeutic system can be mixed with adhesive and formed at a temperature of
20 mere end 90°C. De herved fremstillede terapeutiske transdermale systemer er I20 above 90 ° C. The therapeutic transdermal systems thus produced are I
økonomiske ved fremstillingen og sikrer en konstant overførsel af aktivt stof, idet Ieconomical in preparation and ensures a constant transfer of active substance, I
hele systemets flade klæber til huden.the entire system flat adheres to the skin.
Fremgangsmåde ifølge den kendte teknik til fremstilling af sådanne systemer egner HThe prior art method of producing such systems is suitable for H
25 sig ikke til transdermale systemer, som indeholder temperaturfølsomme stoffer I25 does not apply to transdermal systems containing temperature sensitive substances I
såsom scopolamin. Hidtil er sådanne klæbende aktive stoflag med temperaturføl- Isuch as scopolamine. Heretofore, such adhesive active fabric layers are temperature sensitive
somme aktive stoffer fortrinsvis dannet ud fra opløsning og afdampning af opløs- Isome active substances preferably formed from solution and evaporation of solution
ningsmidlet. I 1 2 3 4 5 6driving means. I 1 2 3 4 5 6
Anvendelsen af opløsningsmidler til fremstilling af klæbelag med aktivt stof er ufor- IThe use of solvents for the production of adhesive layers with active substance is unforeseen
22
delagtig af flere årsager. Fremstillingen af opløsningen kræver mindst ét yderligere Iparticipating for several reasons. The preparation of the solution requires at least one additional I
33
procestrin. Den kræver høj teknologi og yderligere omkostninger til håndtering af Iprocess steps. It requires high technology and additional costs for handling I
44
opløsningsmidlet. Derudover skal der til medicinske formål anvendes meget rene Isolvent. In addition, for medical purposes, very clean I
55
og dermed dyre opløsningsmidler til opløsning af klæbemidlet eller dets udgangs- Hand thus expensive solvents for dissolving the adhesive or its starting H
66
materialer for at sikre en tilsvarende mangel på remanens i indretningen. Et Hmaterials to ensure a corresponding lack of residue in the device. And H
3 DK 175442 B1 yderligere problem består i at fjerne opløsningsmidlerne fra indretningen, hvortil det er nødvendigt med dyre tørringslinjer og udsugningsanlæg. Dertil kommer omkostninger til genvinding og bortskaffelse af opløsningsmidlet for at undgå miljøbelastning. Desuden fremviser opløsningsmidlets brændbarhed en yderligere 5 risiko. Desuden er de fleste organiske opløsningsmidler skadelige for den menneskelige organisme, således at der må tages nødvendige beskyttelsesforanstaltninger for de personer, der arbejder hermed. Det er således opfindelsens opgave at undgå de ovenfor anførte ulemper ved sådanne typer indretninger og fremstillingsmetoden ifølge den kendte teknik.Another problem consists in removing the solvents from the device to which expensive drying lines and extraction systems are needed. In addition, the cost of recycling and disposal of the solvent to avoid environmental impact. In addition, the flammability of the solvent presents an additional 5 risks. In addition, most organic solvents are harmful to the human organism, so the necessary protective measures must be taken for the persons working with them. It is thus the object of the invention to avoid the above-mentioned disadvantages of such types of devices and the method of manufacture according to the prior art.
1010
Opgaven bliver ifølge opfindelsen løst ved en indretning til afgivelse af stoffer fra smelteklæbemidler med uensartet eller ensartet fordeling af stofferne opløst i smelteklæbemidlerne, hvor der foreligger en smelteklæbemiddel/stofblanding eller en opløsning af stoffet i smelteklæbemidlet, hvor smelteklæbemidlet har en forar-15 bejdningstemperatur på mellem 40eC og 80°C, fortrinsvis mellem 40°C og 60°C og især mellem 40°C og 55°C.According to the invention, the task is solved by a device for dispensing substances from melt adhesives having a uniform or even distribution of the substances dissolved in the melt adhesives, where there is a melt adhesive / fabric mixture or a solution of the substance in the melt adhesive, where a melt adhesive has a melt adhesive. 40 ° C and 80 ° C, preferably between 40 ° C and 60 ° C and especially between 40 ° C and 55 ° C.
Der kan herigennem arbejdes ved lave temperaturer uden opløsningsmiddel, hvorved der muliggøres en væsentlig materialebesparelse, en hurtigere fremstilling af 20 indretningen uden tidskrævende tørringstrin samt en mindre miljøbelastende fremstilling af indretningen ifølge den foreliggende opfindelse, hvilket blandt andet fører til et mere økonomisk og opløsningsmiddelfrit produkt.Hereby, it is possible to work at low temperatures without solvent, thereby enabling substantial material savings, faster production of the device without time-consuming drying steps and a less environmentally harmful production of the device according to the present invention, which leads, among other things, to a more economical and solvent-free product.
Indretningen kan således have den/de stof(fer), der skal afgives, og 25 smelteklæbemidlet i ét eller flere lag. Det foretrækkes, at smelteklæbemidlet er forsynet med et bærestof, der er gennemtrængeligt eller ugennemtrængeligt for det/de stof(fer), der skal afgives.Thus, the device may have the substance (s) to be dispensed and the hot melt adhesive in one or more layers. It is preferred that the hot melt adhesive be provided with a carrier which is permeable or impervious to the substance (s) to be released.
Smelteklæbemidlet kan fx være et sådant, der er fremstillet på basis af styren-30 isopren-styren-blokpolymerer, polyaprolactoner, ethylen-vinylacetat-copolymerer, polyurethan, polyepoxider, polyisobuten, polyvinylethere, eventuelt under tilsætning af blødgøringsmidler, klæbriggørende midler, fyldstoffer, ældningsbeskyttelsesmidler og/eller thixotropigivende midler.The melt adhesive may be, for example, one made on the basis of styrene-isoprene-styrene block polymers, polyaprolactones, ethylene-vinyl acetate copolymers, polyurethane, polyepoxides, polyisobutylene, polyvinyl ethers, optionally with the addition of plasticizers, adhesives, adhesives, adhesives, and / or thixotropic agents.
I DK 175442 B1 II DK 175442 B1 I
I II I
I En fremgangsmåde ifølge opfindelsen til fremstilling af en indretning ifølge opfin- II A method according to the invention for producing a device according to the invention
I delsen omfatter, at smeltet smelteklæbemiddel med indhold af det stof, der skal IIn the present invention, the molten adhesive comprising the substance to be contained
I afgives, kontinuerligt eller diskontinuerligt anbringes på et bærestof ved en tem- IYou are delivered, continuously or discontinuously placed on a carrier at a temp
I peratur af smelteklæbemidlet på mellem 40°C og 80°C, fortrinsvis 40°C til 60°C og IAt a temperature of the melt adhesive of between 40 ° C and 80 ° C, preferably 40 ° C to 60 ° C and I
I 5 især 40°C til 55°C, og beskyttelseslaget eventuelt påføres. IIn particular, 40 ° C to 55 ° C, and the protective layer optionally applied. IN
I En yderligere fremgangsmåde ifølge opfindelsen omfatter, at smeltet smelteklæbe- IIn a further method according to the invention, the molten melt adhesive comprises
I middel med indhold af det stof, der skal afgives, kontinuerligt eller diskontinuerligt IContainer containing the substance to be delivered continuously or continuously
I anbringes på et beskyttelseslagmateriale ved en temperatur af smelteklæbemidlet IYou are placed on a protective layer material at a temperature of the melt adhesive I
I 10 på mellem 40°C og 80°C, fortrinsvis 40°C til 60°C og især 40°C til 55°C, og IIn the range of 40 ° C to 80 ° C, preferably 40 ° C to 60 ° C and especially 40 ° C to 55 ° C, and I
I bærestoffet eventuelt påføres. IIf applicable, apply in the carrier. IN
I Ved anvendelse af letflygtige og/eller termisk instabile stoffer, der skal afgives, kan IBy using volatile and / or thermally unstable substances to be emitted, you can:
I der anvises følgende foranstaltninger til forarbejdningen: IThe following processing measures are indicated:
I 15 II 15 I
I A. arbejde ved lavest mulige temperaturer IIn A. work at the lowest possible temperatures
I B. hævning af det ydre tryk for at mindske fordampningen, IB. raising the external pressure to reduce evaporation,
I C. mætning af damprummet over den smeltede masse med dampformigt IIn C. saturation of the steam room over the molten mass with vaporous I
I stof, IIn fabric, I
I 20 D. arbejde med den alt efter opgaven mindst mulige mængde af flygtigt stof i IIn 20 D. work with the least amount of volatile matter in I according to the task
I den smeltede masse. IIn the molten mass. IN
I Selvfølgelig er disse foranstaltninger, som eksempelvis arbejde i et indkapslet IOf course, these are measures, such as working in an encapsulated I
I anlæg, begrænset ved de af fagmanden kendte lovmæssigheder med hensyn til IIn facilities limited by the laws known to those skilled in the art with respect to I
I 25 anvendelsesformålet for den fremstillede indretning og også ved stoffernes IIn the application of the device manufactured and also of the substances I
I egenskaber.In properties.
I Indretningerne ifølge opfindelsen, især de transdermale systemer, kan eksempelvis IFor example, in the devices of the invention, especially the transdermal systems, I
I anvendes til lokal eller systemisk transdermal administration af aktive stoffer i II is used for local or systemic transdermal administration of active substances in I
I 30 human- eller veterinærmedicinen eller til kosmetik, fortrinsvis til afgivelse af tem- IIn human or veterinary medicine or for cosmetics, preferably for the delivery of tem
I peraturfølsomme stoffer og/eller letflygtige stoffer. IIn periorally sensitive substances and / or volatile substances. IN
I Et smelteklæbemiddel kan i nærværende forbindelse være ethvert klæbestof, der IIn this context, a hot melt adhesive may be any adhesive which you
I varmt er tilstrækkelig flydende til uden problemer at blive påført ved en tempe- IIn hot, sufficient liquid to be applied at a tem- perature without difficulty
I 35 ratur på over ca. 40°C. IIn 35 rature of over approx. 40 ° C. IN
5 DK 175442 B15 DK 175442 B1
Som ifølge opfindelsen anvendelige smelteklæbemidler kan der blandt andet anvendes sådanne, som er kendte af fagmanden, og som blandt andet kan udledes af DE-A 15 94 268 (SUN OIL CO.), DE-A 24 13 979 (E.I. DU PONT DE NEMOURS), 5 DE-A 24 35 863 (DYNAMIT NOBEL AG); DE-A 28 00 302 (CIBAGEIGY); EP-A-104 005 (PERSONAL PRODUCTS CO), JP 6104 2583 og JP 61 281 810, EP-A 131 460 (EXXON) og EP-A 234 856 (EX-XON), EP-A 185 992 (EASTMAN KODAK) samt US-PS 36 99 963 og US-PS 4,358,557 (EASTMAN KODAK), hvortil der henvises, idet der til undgåelse af gentagelser udtrykkeligt henvises til dette teknikkens stand-10 punkt.As used in the invention, melt adhesives which can be used, among others, are known to those skilled in the art and which can be derived, inter alia, from DE-A 15 94 268 (SUN OIL CO.), DE-A 24 13 979 (EI DU PONT DE NEMOURS ), 5 DE-A 24 35 863 (DYNAMIT NOBEL AG); DE-A 28 00 302 (CIBAGEIGY); EP-A-104 005 (PERSONAL PRODUCTS CO), JP 6104 2583 and JP 61 281 810, EP-A 131 460 (EXXON) and EP-A 234 856 (EX-XON), EP-A 185 992 (EASTMAN KODAK) as well as US-PS 36 99 963 and US-PS 4,358,557 (EASTMAN KODAK), to which reference is made explicitly to the state of the art for avoidance of repetition.
Som grundpolymerer kan der eksempelvis anvendes polyamider, polyestre, poly-caprolactamer, polycaprolacton, ethylen-vinylacetatcopolymerer (EVA), ethylen-ethylacrylatcopolymerer (EEA), polyvinylethre, polyacrylatestre, polyvinylacetaler, 15 polyvinylacetater, styren-butadien-blokpolymerer, isopren-blokpolymerer, poly-urethaner, ethylcellulose, celluloseacetat-butyrat, syntesekautsjuker (fx neopren-kautsjuk), polyisobutylen, butylgummi, acrylonitril-butadien-blandings-polymeri-sater, epoxidharpikser, melaminharpikser, phenol-formaldehydharpikser og resorcin-formaldehydharpikser, idet blandt andet også de efterfølgende nævnte, 20 modificerede harpikser kan anvendes: hydrogeneret kolophonium, polymeriseret kolophonium, dimeriserede harpikssyrer, disproportioneret kolophonium, methyl-estre af kolophonium, glycerinestre af hydrogeneret kolophonium, methylestre af hydrogeneret kolophonium, pentalester, triethylenglykolestre af hydrogeneret kolophonium, hydroabiethylalkohol og dennes derivater, glycerinestre, ditriolestre 25 og pentaestre af harpikssyrer, pentalestre af polymeriseret kolophonium, pental-estre af dimeriseret kolophonium, glycerinestre af dimeriseret kolophonium, estre af maleinsyre- eller phenolmodificeret kolophonium, aromatiske og aliphatiske carbonhydridharpikser, hydrogenerede harpikser, polyterpenharpikser, modificerede terpenharpikser, voksarter, lavmolekylær polyethylen og polypropylen, alkyl-30 styren-copolymerer. Disse harpikser kan eventuelt tilsættes blødgøringsmidler såsom adipinsyreestre, phosphorsyreestre, phthalsyreestre, polyestre, fedtsyre-estre, citronsyreestre eller epoxid-blødgøringsmidler. Derudover kan også tilblandes stabilisatorer såsom tocopherol, substituerede phenoler, hydroquinon, pyrokatekoler, aromatiske aminer, og eventuelt også fyldstof, fx titandioxid, 35 magnesiumoxid, zinkoxid og siliciumdioxid.As base polymers, for example, polyamides, polyesters, poly-caprolactams, polycaprolactone, ethylene-vinyl acetate copolymers (EVA), ethylene-ethyl acrylate copolymers (EEA), polyvinyl ethers, polyacrylate esters, polyvinyl acetates, polyvinyl acetates, polyvinyl acetates, polyvinyl acetates, polyvinyl acetates, polyvinyl acetates, urethanes, ethyl cellulose, cellulose acetate butyrate, synthetic rubber (e.g. neoprene rubber), polyisobutylene, butyl rubber, acrylonitrile-butadiene blend polymers, epoxide resins, melamine resins, other resins and phenolic formaldehyde resins , 20 modified resins may be used: hydrogenated rosin, polymerized rosin, dimerized resin acids, disproportionate rosin, methyl esters of rosin, glycerin esters of hydrogenated rosin, methyl esters of hydrogenated rosin, pental ester, triethylene glycol esters of hydrogenated rosin, ather, glycerine esters, dithiol esters 25 and penta esters of resin acids, pental esters of polymerized rosin, pental esters of dimerized rosin, glycerin esters of dimerized rosin, esters of maleic acid or phenol modified rosin resins, aromatic and aliphatic hydrocarbon resins , low molecular weight polyethylene and polypropylene, alkyl-styrene copolymers. These resins may optionally be added to plasticizers such as adipic acid esters, phosphoric acid esters, phthalic acid esters, polyesters, fatty acid esters, citric acid esters or epoxide plasticizers. In addition, stabilizers such as tocopherol, substituted phenols, hydroquinone, pyrocatecols, aromatic amines, and optionally filler, for example titanium dioxide, magnesium oxide, zinc oxide and silica, may also be added.
I DK 175442 B1 II DK 175442 B1 I
I II I
Dannelsen af indretningens bestanddele, som omfatter smelteklæbestoffet med en IThe formation of the constituents of the device, which comprises the melt adhesive with an I
I forarbejdningstemperatur på mellem 40°C og 80°C, kan ske ved ekstrusion, støb- IAt processing temperatures between 40 ° C and 80 ° C, extrusion, molding, can occur
ning, kiss-roll-coating, udstrygning, udsprøjtning eller ved en trykkemetode. Icoating, kiss-roll coating, smearing, spraying or by a printing method. IN
Is IIs I
I En grænseværdi for forarbejdeligheden af smelteklæbemidlet ved flere af disse IA limit value for the processability of the hot melt adhesive at several of these
I processer er ved en viskositet på omkring ca. 80.000 Pa s. IIn processes, at a viscosity of about 80,000 Pa. I.
I Hvis grundlaget, der er en komponent i indretningen, og som skal behandles med II If the foundation, which is a component of the device, is to be treated with I
10 klæbemiddel, kan blive beskadiget ved temperaturen af det varmt påførte klæbe- I10 adhesive may be damaged by the temperature of the hot applied adhesive
I middel, det være sig ved nedbrydning, reaktion eller delvis smeltning, kan der IIn the medium, whether by decomposition, reaction or partial melting, you can
I anvendes et afkølet grundlag. Kølingen kan ske ved kendte metoder, såsom ved IYou use a cooled base. The cooling can be done by known methods, such as I
I anvendelse af kold inert gas eller ved kontakt med en køleflade. IWhen using cold inert gas or in contact with a cooling surface. IN
I 15 Smelteklæbemidlet kan eksempelvis påføres iagvis eller i enkelte områder, der IFor example, the hot melt adhesive may be applied occasionally or in individual areas where I
I udviser et forudbestemt mønster på beskyttelseslaget eller afdækningsmaterialet. IYou exhibit a predetermined pattern on the protective layer or cover material. IN
Ved nogle anvendelsesformål - eksempelvis i tilfælde af at det stof, der skal afgi- IFor some applications - for example in the case of the substance to be released
ves, kan afgives gennem dæklaget, som det fx kan ske for etheriske olier såsom Ives, can be delivered through the cover, as can be done, for example, for essential oils such as I
I 20 duftstoffer, kan smelteklæbemidlet være udstyret med et bærestof, der er gen- IIn 20 fragrances, the hot melt adhesive may be provided with a carrier which is recovered.
I nemtrængeligt for det/de stof(-fer), der skal frigøres, idet det ved en udførel- IIn the case of the substance (s) to be released, in an embodiment
sesform af indretningen som transdermalt system, hvor stoffet kun skal afgives til Iform of the device as a transdermal system in which the substance is to be delivered only to I
I huden, foretrækkes at anvende et dæklag, der er uigennemtrængeligt for det stof, IIn the skin, it is preferable to use a coating which is impervious to the substance I
I der skal frigives. IIn there to be released. IN
I 25 II 25 I
I Ved fremgangsmåden ifølge opfindelsen kan anvendelsen af opløsningsmiddelhol- IIn the process according to the invention, the use of solvent can
I dige klæbende materialer nu omgås ved forarbejdning af temperaturfølsomme og · IIn dense adhesive materials are now bypassed by processing of temperature sensitive and · I
I letflygtige stoffer, hvilket fører til øget sikkerhed ved fremstillingen, eftersom der IIn volatile substances, which leads to increased safety during manufacture, since I
nu med sikkerhed ingen toxiske opløsningsmiddelrester er i lægemiddelformule- Inow, no toxic solvent residues are present in drug formula I
I 30 ringen, og fører til en stærkt forenklet påføringsproces og til betydelig reduktion af IIn the ring, leading to a greatly simplified application process and to a significant reduction of I
I fremstillingsomkostningerne. Fremgangsmåden kan naturligvis også med fordel IIn manufacturing costs. The process can, of course, also advantageously I
I anvendes til mindre temperaturfølsomme stoffer, da der også her kan opnås IYou are used for less temperature sensitive substances, as here too you can be obtained
I væsentlig reduktion af omkostningerne. ISubstantially reducing costs. IN
7 DK 175442 B17 DK 175442 B1
Under benævnelsen "stoffer" j forbindelse med den foreliggende opfindelse skal forstis kemiske grundstoffer, organiske og uorganiske forbindelser, der, som en bestanddel indeholdt i én af indretningstyperne, kan vandre ud og derved give anledning til den tilstræbte virkning. Blandt anvendelsesområderne for indretning-5 en ifølge opfindelsen er human- og dyremedicinen af særlig betydning, hvor der især foretrækkes en udførelsesform af opfindelsen i form af plastre.Under the term "substances" in connection with the present invention is understood chemical elements, organic and inorganic compounds which, as a component contained in one of the device types, can migrate out and thereby give rise to the desired effect. Among the application areas of the device according to the invention, the human and animal medicine is of particular importance, whereby an embodiment of the invention in the form of patches is particularly preferred.
Typiske stoffer, som kan administreres via indretninger fremstillet ifølge opfindelsen er: 10Typical substances which can be administered via devices made according to the invention are: 10
Acedidin, amfetaminil, amfetamin, amylnitrit, apophedrin, atebrin, alprostadil, azulen, arecolin, anethol, amylenhydrat, acetylcholin, acridin, adenosintriphosphor-syre, L-aeblesyre, alimemazin, allithiamin, allyiisothiocyanat, aminoethanol, apyzin, apiol, azatadin, alprenolol, ethinazon, benzoylperoxid, benzylalkohol, bisabolol, 15 bisnorephedrin, butacetoluid, benactyzin, kamfer, cholecaldferol, chloralhydrat, clemastin, chlorbutanol, capsaidn, cydopentamin, clobutinol, chamazulen, dimethocain, codein, chlorpromazin, kinin, chlorthymol, cydophosphamid, dnchocain, chlorambuzil, chlorphenesin, diethylethan, divinylethan, dexchlor-pheniramin, dinoproston, dixyrazin, ephedrin, ethosuximid, enallylpropymal, 20 emylcamat, erythroltetranitrat, emetin, enfluran, eucalyptol, etofenamat, ethylmorfin, fentanyl, fluanison, guajazulen, halothan, hyoscyamin, histamin, fencarbamid, hydroxycain, hexylresorcin, isoaminildtrat, iso-sorbiddinitrat, ibupro-fen, iod, iodoform, isoaminil, lidocain, lopirin, levamisol, methadon, methyprylon, methylphenidat, mephenesin, methylephedrin, medastin, methopromazin, mesux-25 imid, nicethamid, norpseudoephedrin, menthol, methoxyfluran, methylpentinol, metixen, misoprostol, oxytetracain, oxyprenolol, oxyphenbutazon, oxyquinolin, pinen, prolintan, procydidin, piperazin, pivazid, phensuximid, procain, phenind-amin, promethazin, pentetrazol, profenamin, perazin, phenol, pethidin, pilocarpin, prenylamin, phenoxybenzamin, resoquin, scopolamin, salicylsyreestre, spartein, 30 trichlorethylen, timolol, trifluperazin, tetracain, trimipramin, tranylcypromin, tri-methanion, tybamat, thymol, thioridazin, valproinsyre, verapamil samt yderligere, for fagmanden sædvanlige aktive stoffer, der kan optages via huden og slimhinderne. Denne liste er naturligvis ikke udtømmende. 1Acedidine, amphetaminil, amphetamine, amyl nitrite, apophedrin, atebrin, alprostadil, azulen, arecoline, anethole, amylene hydrate, acetylcholine, acridine, adenosine triphosphoric acid, L-malic acid, alimemazine, allithiamine, aplyhanolate, allyiisothiocyanate ethinazone, benzoyl peroxide, benzyl alcohol, bisabolol, bisnorephedrine, butacetoluid, benactyzin, camphor, cholecaldferol, chlorohydrate, clemastine, chlorobutanol, capsaidn, cydopentamine, clobutinol, chamazulin, dimethocaine, codeine, chlorine , diethylethane, divinylethane, dexchloropheniramine, dinoprostone, dixyrazine, ephedrine, ethosuximide, enallylpropymal, emylcamate, erythrolethetranitrate, emetin, enflurane, eucalyptol, etofenamate, ethylmorphan, guanyl, fentanyl, fentanyl hexyl resorcin, isoamine filtrate, isosorbide dinitrate, ibuprofen, iodine, iodoform, isoaminil, lidocaine, lopiri n, levamisole, methadone, methyprylon, methylphenidate, mephenesine, methylphedrine, medastine, methopromazine, mesuximide, nicethamide, norpseudoephedrine, menthol, methoxyflurane, methylpentinol, methixen, misoprostol, oxytetracoline, oxyprenoline, oxyprenoline, oxyprenoline , piperazine, pivazide, phensuximide, procaine, phenindamine, promethazine, pentetrazole, profenamine, perazine, phenol, pethidine, pilocarpine, prenylamine, phenoxybenzamine, resoquine, scopolamine, salicylic acid esters, spartein, trichlorethylene, 30 trichlorethylene, 30 trichlorethylene tranylcypromine, tri-methanion, tybamate, thymol, thioridazine, valproic acid, verapamil and, further, to those skilled in the art, usual active substances which can be absorbed through the skin and mucous membranes. Of course, this list is not exhaustive. 1
Typiske sammensætninger af anvendelige smelteklæbemidler er sådanne,Typical compositions of useful hot melt adhesives are such
I DK 175442 B1 II DK 175442 B1 I
I II I
I som er fremstillet ud fra mellem 10 og 100 vægt%, fortrinsvis 20 til 80 vægt% og II which is prepared from between 10 and 100% by weight, preferably 20 to 80% by weight and I
I især 20 til 50 vægt% polymer, mellem 10 og 80 vægt%, fortrinsvis 15 til IIn particular, 20 to 50% by weight of polymer, between 10 and 80% by weight, preferably 15 to 1
I 60 vægt% blødgøringsmiddel; mellem 10 og 80 vægt%, fortrinsvis 15 til IIn 60% by weight plasticizer; between 10 and 80% by weight, preferably 15 to 1
I 60 vægt% klæbriggørende middel; eventuelt 0,1 til 5 vægt% ældningsbeskyttende IIn 60% by weight adhesive; optionally 0.1 to 5% by weight of aging protective I
5 middel og eventuelt 0 til 70 vægt% fyldstof, idet summen af procentsatsen af I5, and optionally 0 to 70% by weight of filler, the sum of the percentage of I
I bestanddelene er 100. IIn the constituents are 100. I
I Det foretrækkes, at smelteklæbestoffet indeholder op til 10 til 50 vægt% styren- IIt is preferred that the hot melt adhesive contains up to 10 to 50% by weight of styrene
I isopren-styren-syntesekautsjuk, som eksempelvis er i handlen under betegnelsen IIn isoprene-styrene synthetic rubber, for example, which is commercially available under the designation I
I 10 CARIFLEX TR 1107 fra SHELL; mellem 10 og 80 vægt% af en hydrogeneret alko- II 10 CARIFLEX TR 1107 from SHELL; between 10 and 80% by weight of a hydrogenated alcohol
hol, som fx kan fås under betegnelsen ABITOL fra HERCULES: mellem 10 og Ihol, which can be obtained, for example, under the designation ABITOL from HERCULES: between 10 and 1
I 80 vægt% af en carbonhydridharpiks, eksempelvis harpiksen HERCURES C fra IIn 80% by weight of a hydrocarbon resin, for example the resin HERCURES C from I
I HERCULES, mellem 1 og 40 vægt% af en ester af en plantefedtsyre, eksempelvis IIn HERCULES, between 1 and 40% by weight of an ester of a plant fatty acid, e.g.
I MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt indtil 5 vægt% ældningsbeskyttel- II MIGLYOL 812 from DYNAMIT NOBEL and optionally up to 5% by weight of aging protection I
I 15 sesmiddel, såsom hydroquinon etc., samt indtil 70 vægt% fyldstof. IIn solvent, such as hydroquinone, etc., and up to 70% by weight of filler. IN
I en yderligere foretrukken udførelsesform ifølge opfindelsen indeholder smelte- IIn a further preferred embodiment of the invention, the melt contains
I klæbemidlet op til 10 til 50 vægt% af en polycaprolacton, eksempelvis CAPA 650 IIn the adhesive up to 10 to 50% by weight of a polycaprolactone, for example CAPA 650 I
I fra INTEROX; mellem 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis II from INTEROX; between 10 and 80% by weight of a hydrogenated alcohol, for example I
I 20 ABITOL fra HERCULES; mellem 10 og 80 vægt% afen carbonhydridharpiks, II 20 ABITOL from HERCULES; between 10 and 80% by weight of a hydrocarbon resin, I
I eksempelvis HERCURES C fra HERCULES; mellem 1 og 40 vægt% af en ester af en IFor example, in HERCURES C from HERCULES; between 1 and 40% by weight of an ester of an I
I plantefedtsyre, såsom MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt op til 5 IIn plant fatty acid such as MIGLYOL 812 from DYNAMIT NOBEL and optionally up to 5 I
I vægt% ældningsbeskyttelsesmiddel, samt op til 70 vægt% fyldstof. IBy weight% of age-protecting agent, and up to 70% by weight of filler. IN
I 25 Det kan også være foretrukket, at smelteklæbestoffet indeholder op til 10 til II It may also be preferred that the hot melt adhesive contains up to 10 to 1
I 50 vægt% polyethylen-vinylacetat, såsom EVATANE 28-25 fra ATOCHEM, mellem IIn 50% by weight polyethylene vinyl acetate, such as EVATANE 28-25 from ATOCHEM, between I
I 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis ABITOL fra HERCULES, IIn 10 and 80% by weight of a hydrogenated alcohol, for example ABITOL from HERCULES, I
I mellem 10 og 80 vægt% af et carbonhydrid-harpiks, eksempelvis harpiks IIn between 10 and 80% by weight of a hydrocarbon resin, for example resin I
I HERCURES C fra HERCULES; mellem 1 og 40 vægt% af en ester af en plante- II HERCURES C from HERCULES; between 1 and 40% by weight of an ester of a plant I
I 30 fedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt indtil IIn 30 fatty acids, for example, MIGLYOL 812 from DYNAMIT NOBEL and optionally until I
I 5 vægt% ældningsbeskyttelsesmiddel, såsom hydroquinon etc., samt op til IIn 5% by weight of age-protecting agent, such as hydroquinone etc., and up to 1
I 70 vægt% fyldstof. IIn 70% by weight filler. IN
I Et egnet smelteklæbemiddel kan indeholde op til 10 til 50 vægt% polyurethan; IA suitable hot melt adhesive may contain up to 10 to 50% by weight of polyurethane; IN
I 35 som eksempelvis LUPHEN P 1110 fra BASF; mellem 10 og 80 vægt% af en IIn 35 such as LUPHEN P 1110 from BASF; between 10 and 80% by weight of an I
9 DK 175442 B1 hydroge-neret alkohol, eksempelvis ABITOL fra HERCULES; mellem 10 og 80 vægt% af en carbonhydridharpiks, eksempelvis harpiksen HERCURES C fra HERCULES; mellem 1 og 40 vægt% af en ester af en plantefedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt indtil 5 vægt% ældningsbeskyt-5 telsemiddel, samt op til 70 vægt% fyldstof.9 DK 175442 B1 hydrogenated alcohol, for example ABITOL from HERCULES; between 10 and 80% by weight of a hydrocarbon resin, for example, the HERCURES C resin from HERCULES; between 1 and 40% by weight of an ester of a plant fatty acid, for example MIGLYOL 812 from DYNAMIT NOBEL and optionally up to 5% by weight of aging protection agent, and up to 70% by weight of filler.
Det er også muligt, at smelteklæbestoffet indeholder op til 10 til 50 vægt% polyamid, som fx EURELON 930 fra SCHERING; mellem 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis ABITOL fra HERCULES; mellem 10 og 80 vægt% af 10 en carbonhydridharpiks, eksempelvis harpiksen HERCURES C fra HERCULES; mellem 1 og 40 vægt% af en ester af en plantefedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt op til 5 vægt% ældningsbeskyttelsesmiddel, samt op til 70 vægt% fyldstof.It is also possible that the hot melt adhesive contains up to 10 to 50% by weight polyamide, such as EURELON 930 from SCHERING; between 10 and 80% by weight of a hydrogenated alcohol, for example ABITOL from HERCULES; between 10 and 80% by weight of a hydrocarbon resin, for example the HERCURES C resin from HERCULES; between 1 and 40% by weight of an ester of a plant fatty acid, for example, MIGLYOL 812 from DYNAMIT NOBEL and optionally up to 5% by weight of aging protection agent, and up to 70% by weight of filler.
15 Der kan også anvendes et smelteklæbestof med 10 til 50 vægt% epoxid, eksempelvis EUREPOX 7001 fra SCHERING; mellem 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis ABITOL fra HERCULES; mellem 10 og 80 vægt% af en carbonhydridharpiks, eksempelvis harpiksen HERCURES C fra HERCULES; mellem 1 og 40 vægt% af en ester af en plantefedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT 20 NOBEL og eventuelt op til 5 vægt% ældningsbeskyttelsesmiddel, såsom hydro-quinon etc., samt op til 70 vægt% fyldstof.A melt adhesive with 10 to 50% by weight epoxide can also be used, for example EUREPOX 7001 from SCHERING; between 10 and 80% by weight of a hydrogenated alcohol, for example ABITOL from HERCULES; between 10 and 80% by weight of a hydrocarbon resin, for example, the HERCURES C resin from HERCULES; between 1 and 40% by weight of an ester of a plant fatty acid, for example, MIGLYOL 812 from DYNAMIT 20 NOBEL and optionally up to 5% by weight of antifouling agent such as hydroquinone etc., and up to 70% by weight of filler.
Et yderligere anvendeligt smelteklæbemidde! til fremstilling af transdermale systemer ifølge opfindelsen indeholder op til 10 til 50 vægt% polyisobuten med 25 sejtklæbende kautsjukagtig konsistens, som fx OPPANOL B 50 fra BASF, mellem 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis ABITOL fra HERCULES, mellem 10 og 80 vægt% af en carbonhydridharpiks, eksempelvis harpiksen HERCURES C fra HERCULES, mellem 1 og 40 vægt% af en ester af en plantefedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT NOBEL og eventuelt indtil 5 vægt% 30 ældningsbeskyttelsesmiddel, samt indtil 70 vægt% fyldstof.A further useful melt adhesive! for the preparation of transdermal systems according to the invention contains up to 10 to 50% by weight polyisobutene with 25 sticky rubbery consistency, such as OPPANOL B 50 from BASF, between 10 and 80% by weight of a hydrogenated alcohol, eg ABITOL from HERCULES, between 10 and 80 wt% of a hydrocarbon resin, for example the resin HERCURES C from HERCULES, between 1 and 40 wt% of an ester of a plant fatty acid, for example MIGLYOL 812 from DYNAMIT NOBEL and optionally up to 5 wt% 30 antifouling agent and up to 70 wt% filler.
Endelig foretrækkes det at anvende smelteklæbemidler på polyesterbasis, som eksempelvis indeholder mellem 10 og 80 vægt% af en hydrogeneret alkohol, eksempelvis ABITOL fra HERCULES, mellem 10 og 80 vægt% af en carbonhydrid-35 harpiks, eksempelvis harpiksen HERCURES C fra HERCULES, mellem 1 ogFinally, it is preferred to use polyester-based melt adhesives containing, for example, between 10 and 80% by weight of a hydrogenated alcohol, e.g., ABITOL from HERCULES, between 10 and 80% by weight of a hydrocarbon resin, e.g., the HERCURES C resin from HERCULES, between 1 and
I DK 175442 B1 II DK 175442 B1 I
I 10 II 10 I
I 40 vægt% af en ester af en plantefedtsyre, eksempelvis MIGLYOL 812 fra DYNAMIT IIn 40% by weight of an ester of a plant fatty acid, for example MIGLYOL 812 from DYNAMIT I
I NOBEL og eventuelt op til 5 vægt% ældningsbeskyttelsesmiddel, samt op til IIn NOBEL and optionally up to 5% by weight of anti-aging agent, and up to I
I 70 vægt% fyldstof. IIn 70% by weight filler. IN
I 5 Indretninger ifølge opfindelsen kan yderligere have ét eller flere stofdepoter, i IDevices according to the invention may further have one or more fabric depots, in one
I hvilke(t) stoffet foreligger med en højere koncentration end i smelteklæbelaget IIn which (s) the substance is present at a higher concentration than in the melt adhesive layer I
I med aktivt stof, hvorved der kan arbejdes med højere doser af stof, og hvorved IWith active substance, you can work with higher doses of the substance and thereby
I indretningen kan forblive på applikationsstedet i længere tid, før den skal udskiftes. IIn the device can remain at the application site for a long time before it needs to be replaced. IN
I Typiske udformninger findes eksempelvis i DE-OS 36 29 304.0. Foretrukne udform- ITypical designs can be found, for example, in DE-OS 36 29 304.0. Preferred designs
I 10 ninger ifølge opfindelsen er anført i de uselvstændige krav, hvortil henvises. IThe invention according to the invention is set out in the dependent claims to which reference is made. IN
I Yderligere ejendommeligheder og fordele ved opfindelsen bliver efterfølgende IFurther features and advantages of the invention subsequently become
I forklaret ved den vedlagte tegning. IAs explained in the accompanying drawing. IN
I 15 Denne viser: II 15 This shows: I
I Fig. 1 et skematisk snit gennem lagene af en indretning ifølge IIn FIG. 1 is a schematic section through the layers of a device according to I
I opfindelsen med et stofdepot. IIn the invention with a fabric depot. IN
I Fig. 2 et skematisk snit gennem en yderligere indretning ifølge IIn FIG. 2 is a schematic section through a further device according to I
I 20 opfindelsen med et depot af aktivt stof, og IIn the invention with an active substance depot, and I
I Fig. 3 et skematisk snit gennem en yderligere udførelsesform af IIn FIG. 3 is a schematic section through a further embodiment of I
I indretningen ifølge opfindelsen uden stofdepot. IIn the device according to the invention without a dust deposit. IN
I I fig. 1 er vist en indretning ifølge opfindelsen, her afbildet som et plasteragtigt, IIn FIG. 1 is a device according to the invention, depicted here as a patchy, I
I 25 transdermalt terapeutisk system med aktivt stof. Den har et smelteklæbelag 12, et IIn an active substance transdermal therapeutic system. It has a melt adhesive layer 12, an I
I depot af aktivt stof 14, i hvilket det aktive stof optræder i mindst en højere kon- IIn the deposit of active substance 14, in which the active substance is present in at least one higher concentration
I centration end i smelteklæbelaget, ligesom et bærestof 10, der ikke tillader aktivt IIn centration than in the melt adhesive layer, like a carrier 10 which does not allow active I
I stof at trænge igennem, på hvilket depotet af aktivt stof 14 ligger, og som er IIn the substance to penetrate, on which the repository of active substance 14 lies, and which is I
I klæbet til huden 18. Det aktive stof vandrer nu kontinuerligt og med forudbestemt IIn the adhesive to the skin 18. The active substance now migrates continuously and with predetermined I
I 30 hastighed gennem huden 18, hvorved indholdet af aktivt stof i laget 12 aftager. IAt a speed through the skin 18, whereby the content of active substance in the layer 12 decreases. IN
I Reduktionen af aktivt stof bliver kompenseret ved udstrømning af aktivt stof fra IThe reduction of active substance is compensated by the outflow of active substance from I
I depotet 14, således at der i et forudbestemt tidsrum hersker en ligevægtskon- IIn the repository 14, so that for a predetermined period of time, a balance equilibrium prevails
I centration af det aktive stof i smelteklæbelaget 12, hvorved der afgives en IIn the center of the active substance in the melt adhesive layer 12, whereby an I
I konstant mængde aktivt stof til huden 18. IIn constant amount of active substance to the skin 18. I
I 35 II 35 I
11 DK 175442 B1 I fig. 2 er vist en yderligere foretrukken udførelsesform af indretningen ifølge opfindelsen, i hvilken et depot 14 af aktivt stof til alle sider er omgivet af smel-teklæbelaget. Denne udførelsesform er især velegnet, nir der ønskes en stor kontaktflade mellem depotet af aktivt stof og smelteklæbelaget for at opnå en 5 hurtig afgivelse af aktivt stof til smelteklæbelaget.11 DK 175442 B1 In fig. 2 is a further preferred embodiment of the device according to the invention, in which an active substance depot 14 is surrounded on all sides by the melt-adhesive layer. This embodiment is particularly suitable when a large contact surface is desired between the active substance deposit and the melt adhesive layer to obtain a rapid release of active substance into the melt adhesive layer.
' I fig. 3 er vist en yderligere enkel udførelsesform af en indretning ifølge opfin delsen, ved hvilken der på et dæklagmateriale 10, der er uigennemtrængeligt for aktivt stof, er anbragt et aktivt stofholdigt smelteklæbelag 12 på en sådan måde, 10 at dæklagmaterialet 10 dækker smelteklæbelaget på tre sider. Det er ved den frie smelteklaebeflade klæbet til huden 18, således at der garanteres en total fladekontakt i hele applikationstiden, og overgangen af aktivt stof til huden sker over en konstant flade med konstant hastighed.In FIG. 3, a further simple embodiment of a device according to the invention is shown, in which an active substance-containing melt adhesive layer 12 is placed on a covering layer 10 impermeable to active substance 10 such that the covering layer material 10 covers the melt adhesive layer on three sides. . It is adhered to the skin at the free hot-melt adhesive so that a total surface contact is guaranteed throughout the application time, and the transition of active substance to the skin occurs over a constant surface at a constant rate.
15 I det efterfølgende beskrives den ifølge opfindelsen forbedrede fremstilling af en indretning ifølge opfindelsen.In the following, the improved preparation of a device according to the invention is described.
Der fremstilles først en blanding af komponenterne af smelteklæbemidlet med det stof, der skal indgives. Denne blanding bringes til forarbejdningstemperatur og 20 anbringes dernæst i smeltet tilstand på et bæremateriale. Den videre forarbejdning såsom anbringelse af et aftageligt beskyttelsesmateriale sker på sædvanlig måde.First, a mixture of the components of the hot melt adhesive is prepared with the substance to be administered. This mixture is brought to processing temperature and then placed in a molten state on a support material. Further processing such as the application of a removable protective material is carried out in the usual manner.
Claims (11)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3729165 | 1987-09-01 | ||
DE3729165 | 1987-09-01 | ||
DE3743945 | 1987-12-23 | ||
DE19873743945 DE3743945A1 (en) | 1987-09-01 | 1987-12-23 | DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
DE8800477 | 1988-08-03 | ||
PCT/DE1988/000477 WO1989001787A1 (en) | 1987-09-01 | 1988-08-03 | Device for release of substances, process for its manufacture and use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
DK210289A DK210289A (en) | 1989-04-28 |
DK210289D0 DK210289D0 (en) | 1989-04-28 |
DK175442B1 true DK175442B1 (en) | 2004-10-25 |
Family
ID=25859260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198902102A DK175442B1 (en) | 1987-09-01 | 1989-04-28 | Apparatus for dispensing substances and method of manufacture and use thereof |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0305756B1 (en) |
JP (1) | JP2781579B2 (en) |
KR (1) | KR970006448B1 (en) |
AT (1) | ATE83655T1 (en) |
AU (1) | AU636835B2 (en) |
CA (1) | CA1333688C (en) |
CZ (1) | CZ281743B6 (en) |
DE (2) | DE3743945A1 (en) |
DK (1) | DK175442B1 (en) |
ES (1) | ES2036242T3 (en) |
FI (1) | FI96577C (en) |
GR (1) | GR3006666T3 (en) |
HU (1) | HU205268B (en) |
IE (1) | IE62943B1 (en) |
IL (1) | IL87538A (en) |
MY (1) | MY103757A (en) |
NO (1) | NO178684C (en) |
NZ (1) | NZ225918A (en) |
PL (1) | PL163710B1 (en) |
PT (1) | PT88378B (en) |
SK (1) | SK279300B6 (en) |
WO (1) | WO1989001787A1 (en) |
YU (1) | YU47201B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3743946A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING NITROGLYCERIN TO THE SKIN, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
HU203285B (en) * | 1988-02-01 | 1991-07-29 | Egyt Gyogyszervegyeszeti Gyar | Method for producing transdermal preparation containing vegetable extract |
JP2758002B2 (en) * | 1988-09-14 | 1998-05-25 | 積水化学工業株式会社 | Patch |
DE3843238C1 (en) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE3843237A1 (en) * | 1988-12-22 | 1990-07-05 | Lohmann Therapie Syst Lts | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT |
DE3843239C1 (en) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE4031881C2 (en) * | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Solvent-free, oral sustained-release pharmaceutical preparation and process for its preparation |
DE4237252C2 (en) | 1992-11-04 | 1994-10-13 | Zweckform Buero Prod Gmbh | Flexible, removable, residue-free removable fabric, process for its production and its use |
DE4301781C2 (en) * | 1993-01-23 | 1995-07-20 | Lohmann Therapie Syst Lts | Patch containing nitroglycerin, process for its production and use |
DE4332094C2 (en) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Active substance plaster which can be produced without solvent and process for its preparation |
US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
DE4403487C2 (en) * | 1994-02-04 | 2003-10-16 | Lohmann Therapie Syst Lts | Pharmaceutical patches with UV-crosslinkable acrylate copolymers |
DE19650471A1 (en) * | 1996-12-05 | 1998-06-10 | Beiersdorf Ag | Patches containing active ingredient |
DE19700913C2 (en) * | 1997-01-14 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for the delivery of hormones |
DE19825499C2 (en) | 1998-06-08 | 2003-07-17 | Beiersdorf Ag | Patches containing active ingredients |
DE19834496B4 (en) * | 1998-07-31 | 2004-02-26 | Beiersdorf Ag | Improved release of ibuprofen from hotmelt adhesives in plasters containing active ingredients by adding pharmaceutical auxiliaries and using auxiliaries to improve the release of ibuprofen |
DE19911262C2 (en) * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Device for dispensing cosmetic active ingredients |
FR2810238B1 (en) | 2000-06-15 | 2002-07-19 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
FR2810239B1 (en) * | 2000-06-15 | 2002-12-20 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
FR2810237B1 (en) * | 2000-06-15 | 2002-07-26 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
DE10041478A1 (en) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | New pharmaceutical composition |
DE10056009A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Well tolerated plaster for controlled delivery of hyperemic agents, having active agent-containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and filler |
DE10118282A1 (en) | 2001-04-12 | 2002-12-05 | Lohmann Therapie Syst Lts | Pressure sensitive adhesive based on ethylene-vinyl acetate copolymers and adhesive resins, for medical purposes |
WO2003061613A1 (en) | 2002-01-24 | 2003-07-31 | L'oreal | Composition containing a semi-crystalline polymer and an ester |
DE10234673B4 (en) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS |
DE10236319A1 (en) * | 2002-08-08 | 2004-02-19 | Beiersdorf Ag | Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer |
JP2004277345A (en) * | 2003-03-17 | 2004-10-07 | Daikyo Yakuhin Kogyo Kk | Plaster and method for producing the same |
DE10312062A1 (en) * | 2003-03-18 | 2004-09-30 | Tesa Ag | Low-shrinkage hotmelt pressure sensitive adhesive, process for its production and use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923939A (en) * | 1974-06-07 | 1975-12-02 | Alza Corp | Process for improving release kinetics of a monolithic drug delivery device |
JPS55141408A (en) * | 1979-04-19 | 1980-11-05 | Hisamitsu Pharmaceut Co Inc | Novel plaster containing steroid and its production |
US4725272A (en) * | 1981-06-29 | 1988-02-16 | Alza Corporation | Novel bandage for administering beneficial drug |
GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
JPS58141225A (en) * | 1982-02-16 | 1983-08-22 | Takasago Corp | Resin composition for fragrant material |
CA1239318A (en) * | 1983-04-27 | 1988-07-19 | Hans R. Hoffmann | Pharmaceutical product preferably in medical bandage form and process for producing them |
US4564364A (en) * | 1983-05-26 | 1986-01-14 | Alza Corporation | Active agent dispenser |
ATE95430T1 (en) * | 1984-12-22 | 1993-10-15 | Sanol Arznei Schwarz Gmbh | ACTIVE PATCHES. |
DE3629304A1 (en) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF |
JPH0816053B2 (en) * | 1986-12-04 | 1996-02-21 | 大正製薬株式会社 | Method of manufacturing patch |
DE3743946A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING NITROGLYCERIN TO THE SKIN, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1987
- 1987-12-23 DE DE19873743945 patent/DE3743945A1/en active Granted
-
1988
- 1988-08-03 DE DE8888112630T patent/DE3876898D1/en not_active Expired - Lifetime
- 1988-08-03 WO PCT/DE1988/000477 patent/WO1989001787A1/en active IP Right Grant
- 1988-08-03 KR KR1019890700772A patent/KR970006448B1/en not_active Expired - Fee Related
- 1988-08-03 HU HU884702A patent/HU205268B/en not_active IP Right Cessation
- 1988-08-03 ES ES198888112630T patent/ES2036242T3/en not_active Expired - Lifetime
- 1988-08-03 EP EP88112630A patent/EP0305756B1/en not_active Expired - Lifetime
- 1988-08-03 JP JP63506544A patent/JP2781579B2/en not_active Expired - Lifetime
- 1988-08-03 AU AU22506/88A patent/AU636835B2/en not_active Ceased
- 1988-08-03 AT AT88112630T patent/ATE83655T1/en not_active IP Right Cessation
- 1988-08-10 MY MYPI88000912A patent/MY103757A/en unknown
- 1988-08-19 CA CA000575201A patent/CA1333688C/en not_active Expired - Lifetime
- 1988-08-22 IE IE255488A patent/IE62943B1/en not_active IP Right Cessation
- 1988-08-23 IL IL8753888A patent/IL87538A/en not_active IP Right Cessation
- 1988-08-24 NZ NZ225918A patent/NZ225918A/en unknown
- 1988-08-31 CZ CS885873A patent/CZ281743B6/en not_active IP Right Cessation
- 1988-08-31 PT PT88378A patent/PT88378B/en not_active IP Right Cessation
- 1988-08-31 SK SK5873-88A patent/SK279300B6/en unknown
- 1988-09-01 PL PL88274486A patent/PL163710B1/en unknown
- 1988-09-01 YU YU166288A patent/YU47201B/en unknown
-
1989
- 1989-04-12 NO NO891507A patent/NO178684C/en unknown
- 1989-04-28 DK DK198902102A patent/DK175442B1/en not_active IP Right Cessation
- 1989-04-28 FI FI892053A patent/FI96577C/en not_active IP Right Cessation
-
1992
- 1992-12-24 GR GR920403040T patent/GR3006666T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK175442B1 (en) | Apparatus for dispensing substances and method of manufacture and use thereof | |
US5273757A (en) | Apparatus for the delivery of substances, processes for the production thereof and use thereof | |
FI96578B (en) | Method for preparing a nitroglycerin donating patch | |
AU613945B2 (en) | Device for controlled release of nicotine, process for manufacturing it, and use thereof | |
EP0622075A1 (en) | Transdermal delivery of active drugs | |
CZ184195A3 (en) | Nitroglycerin containing adhesive plaster and process for preparing thereof | |
US5306502A (en) | Apparatus for delivering nitroglycerin to the skin, processes for the production thereof and the use thereof | |
HRP920857A2 (en) | Apparatus for the delivery of substances process for the production and use thereof | |
HRP920832A2 (en) | Device for the release of nitro-glycirine on the skin, methods of manufacture and use | |
HRP920852A2 (en) | Apparatus for the controlled delivery of nicotine, process the production and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |